HIRSCHMAN ORIN 13D and 13G filings for AVEO Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-10-20 4:05 pm Sale |
2022-10-16 | 13G | AVEO Pharmaceuticals, Inc. AVEO |
HIRSCHMAN ORIN | 975,993 2.800% |
-1,735,377 (-64.00%) |
Filing |
| 2022-02-11 3:32 pm Purchase |
2021-12-31 | 13G | AVEO Pharmaceuticals, Inc. AVEO |
HIRSCHMAN ORIN | 2,711,370 7.900% |
669,559 (+32.79%) |
Filing |
| 2021-09-14 6:11 pm Purchase |
2021-09-03 | 13G | AVEO Pharmaceuticals, Inc. AVEO |
HIRSCHMAN ORIN | 2,041,811 5.940% |
2,041,811 (New Position) |
Filing |